Two fossil claws found on Seymour Island reveal phorusrhacids, or terror birds, lived in Antarctica 50 million years ago. Plus: bilingual exposures may start in the uterus. |
|
|
Like what you see? Subscribe today to gain unlimited access to all our subscriber only content. |
|
|
C. Acosta Hospitaleche & W. Jones/Palaeontological Association 2024 |
|
|
A 2-metre-tall flightless bird may have been the top predator in what is now Antarctica 50 million years ago. Two 8-centimetre fossil claws found on Seymour Island, near the tip of the Antarctic Peninsula, belonged to a large family of similar birds that palaeontologists call terror birds, according to an analysis by Carolina Acosta Hospitaleche at the National University of La Plata in Argentina and Washington Jones at the National Museum of Natural History in Montevideo, Uruguay. Formally called phorusrhacids, terror birds were the apex predators in what is now South America from 53 million years ago to 100,000 years ago, when they went extinct. Read more
|
|
|
Babies born to bilingual mothers who were exposed to two languages in the uterus exhibit different brain responses to speech-like sounds at just a few days old compared with those born to monolingual mothers, further suggesting the influence of prenatal experiences on language acquisition. Researchers recruited 131 full-term babies aged between 1 and 3 days old, 53 of whom had mothers who spoke only Spanish and 78 of whom had mothers who spoke both Spanish and Catalan. They recorded their brain activity while the babies were played a series of “oa” sounds, finding that the bilingual-exposed infants showed signs of better-quality neural patterns. Read more
|
|
|
| These 7 mathematical facts will blow your mind. Enjoy a selection of our favourite recent stories from the world of mathematics - free for a limited time. |
|
|
Long read: Ketamine's medicinal potential |
|
|
Victor Llorente/The New York Times/Redux/eyevine |
|
|
Ketamine has more typically been known as a rave drug or a horse tranquiliser. Today it is the most commonly prescribed form of psychedelic-assisted therapy, with fresh evidence it can treat depression, post-traumatic stress disorder and addiction – although exactly how it works is unclear. Some companies are even offering ketamine therapy as part of their employee health benefits. Pharmaceutical companies, meanwhile, are developing over-the-counter ketamine products such as lozenges and topical creams. So can ketamine really soothe mental health problems and what are the risks of making this novel treatment too easy to access? Read more
|
|
|
New Scientist subscriptions |
|
|
|
Artificial intelligence is advancing at a breathtaking speed. Get unlimited access to the latest news and in-depth research surrounding the prospects and pitfalls that artificial intelligence poses and how this will likely impact our society. |
|
|
"The moment is grave and we still aren’t at the peak of the epidemic." |
|
|
This email has been sent to subscriber@example.com. Unsubscribe from the Daily newsletter |
Do not reply directly to this email. If you have an enquiry, please contact us using the relevant contact details listed here. |
Copyright © New Scientist Ltd Registered Office: Northcliffe House, 2 Derry Street, London, W8 5TT Registered in England. No.10644366 Australian mailing address: PO Box 2315, Strawberry Hills, NSW 2012, Australia Registered in Australia. ABN 22 621 413 170
Privacy Policy | Terms & Conditions |
|
|
|
|
|
|